Pharma Mar | PHM - Equity Capital And Reserves


Pharma Mar reported EUR249.67M in Equity Capital and Reserves for its fiscal quarter ending in March of 2026.





Equity Capital And Reserves Change Date
Akebia Therapeutics USD 27.38M 5.24M Mar/2026
Alaunos Therapeutics USD 1.29M 865K Mar/2026
Almirall EUR 1.49B 24.03M Dec/2025
Avita Medical AUD -16.65M 3.76M Dec/2025
Dianthus Therapeutics USD 1.2B 707.91M Mar/2026
Ionis Pharmaceuticals USD 491.41M 2.32M Mar/2026
IQVIA Holdings USD 6.22B 282M Mar/2026
Laboratorios Farma EUR 539.39M 22.74M Dec/2023
Moderna USD 7.41B 1.24B Mar/2026
Organon & Co USD 903M 151M Mar/2026
Pharma Mar EUR 249.67M 2.16M Mar/2026
Revvity USD 7.25B 125.54M Dec/2025
Tectonic Therapeutic USD 230.42M 20.91M Mar/2026
Viatris USD 14.66B 53.6M Mar/2026
Xeris Pharmaceuticals USD 13.01M 678K Mar/2026